OAB Delivery Catheter
Cognition Medical Corp. · Decision date Oct 2, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the OAB Delivery Catheter, submitted by Cognition Medical Corp. under 510(k) number K253422, with a decision date of October 2, 2026. The device is a Class II percutaneous catheter under 21 CFR 870.1250, carrying product codes QJP and DQY, with the database listing the regulation medical specialty as Cardiovascular and the review panel as Neurology. SESE denotes 510(k) clearance, not premarket approval.
The submission summary describes a variable stiffness, single-lumen catheter reinforced with metal braid, coil and polymer layers, a tapered tip with radiopaque markers, a hydrophilic-coated distal shaft, and ethylene oxide sterilization for single use. It lists the NG Delivery Catheter (K230609) as predicate and the Wedge Microcatheter (K172014) as reference device. The database shows a date received of 10/01/2025, which differs from the September 1, 2026 dates in the FDA letter; the reason for the discrepancy is not stated in the available text. The summary's testing section was not included in the excerpts, so performance data are unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253422
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Cognition Medical Corp.
- Product code
- QJP
- Decision code
- SESE
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Percutaneous, Neurovasculature.
- Applicant
- Cognition Medical Corp.
- Product code
- QJP
- FDA device class
- 2
FDA decision timeline
K253422 received
Application receipt date recorded by FDA.
K253422 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QJP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NeuroSheathK261449 | Perfuze, Ltd. | 510(k) clearance | Nov 5, 2026 | FDA |
| Stryker Neurovascular | 510(k) clearance | Oct 9, 2026 | FDA | |
APRO 88 CatheterK261938 | Alembic, LLC | 510(k) clearance | Oct 6, 2026 | FDA |
| Route 92 Medical, Inc. | 510(k) clearance | Sep 16, 2026 | FDA | |
70 NeuGlide CatheterK262277 | Piraeus Medical, Inc. | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cognition Medical Corp.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Atlanta, GA
Sources and methodology
- Original FDA record: K253422
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

